1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           North America In-Vitro Diagnostics Market - Key Industry Dynamics

4.1       Key Market Drivers

4.1.1         Increasing Prevalence of Chronic and Infectious Diseases

4.1.2         Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic

4.2       Market Restraint

4.2.1         Insufficiency of Regulatory Frameworks and Reimbursement Policies

4.3       Market Opportunities

4.3.1         Integration of IVD with Digital Health Technologies

4.4       Future Trends

4.4.1         Increasing Demand for Personalized Medicine and Genomics

5.           In-Vitro Diagnostics Market – North America Market Analysis

5.1       North America In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030

6.           North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services

6.1       Overview

6.2       North America In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

6.3       Reagents and Kits

6.3.1         Overview

6.3.2         Reagents and Kits: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

6.4       Software and Services

6.4.1         Overview

6.4.2         Software and Services: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

6.5       Instruments

6.5.1         Overview

6.5.2         Instruments: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.           North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Technology

7.1       Overview

7.2       North America In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

7.3       Immunoassay/ Immunochemistry

7.3.1         Overview

7.3.2         Immunoassay/ Immunochemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Clinical Chemistry

7.4.1         Overview

7.4.2         Clinical Chemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

7.5       Molecular Diagnostics

7.5.1         Overview

7.5.2         Molecular Diagnostics: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

7.6       Microbiology

7.6.1         Overview

7.6.2         Microbiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.7       Blood Glucose Self-Monitoring

7.7.1         Overview

7.7.2         Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.8       Coagulation and Hemostasis

7.8.1         Overview

7.8.2         Coagulation and Hemostasis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.9       Hematology

7.9.1         Overview

7.9.2         Hematology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.10     Urinalysis

7.10.1       Overview

7.10.2       Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.11     Others

7.11.1       Overview

7.11.2       Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.           North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Application

8.1       Overview

8.2       North America In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)

8.3       Infectious Disease

8.3.1         Overview

8.3.2         Infectious Diseases: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Diabetes

8.4.1         Overview

8.4.2         Diabetes: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5       Oncology

8.5.1         Overview

8.5.2         Oncology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.6       Cardiology

8.6.1         Overview

8.6.2         Cardiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.7       Autoimmune Diseases

8.7.1         Overview

8.7.2         Autoimmune Diseases: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

8.8       Nephrology

8.8.1         Overview

8.8.2         Nephrology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.9       Others

8.9.1         Overview

8.9.2         Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.           North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by End User

9.1       Overview

9.2       North America In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

9.3       Hospitals

9.3.1         Overview

9.3.2         Hospitals: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Laboratories

9.4.1         Overview

9.4.2         Laboratories: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Homecare

9.5.1         Overview

9.5.2         Homecare: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.6       Others

9.6.1         Overview

9.6.2         Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.        North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – Country Analysis

10.1     North America In-Vitro Diagnostics Market

10.1.1       Overview

10.1.2       North America In-Vitro Diagnostics Market, by Country

10.1.2.1          US: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.1.1        Overview

10.1.2.1.2        US: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.1.3        US: North America In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.1.4        US: North America In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.1.5        US: North America In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.1.6        US: North America In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.2          Canada: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.2.1        Overview

10.1.2.2.2        Canada: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.2.3        Canada: North America In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.2.4        Canada: North America In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.2.5        Canada: North America In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.2.6        Canada: North America In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.3          Mexico: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.3.1        Overview

10.1.2.3.2        Mexico: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.3.3        Mexico: North America In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.3.4        Mexico: North America In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.3.5        Mexico: North America In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.3.6        Mexico: North America In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

11.        Industry Landscape

11.1     Organic Developments

11.1.1       Overview

11.2     Inorganic Developments

11.2.1       Overview

12.        Company Profiles

12.1     Abbott Laboratories

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     F. Hoffmann-La Roche Ltd

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     Danaher Corp

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     Siemens AG

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     Sysmex Corp

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     Thermo Fisher Scientific Inc

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     Becton Dickinson and Co

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8     bioMerieux SA

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9     Bio-Rad Laboratories Inc

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10  Qiagen NV

12.10.1    Key Facts

12.10.2    Business Description

12.10.3    Products and Services

12.10.4    Financial Overview

12.10.5    SWOT Analysis

12.10.6    Key Developments

13.        Appendix

13.1     About Us

13.2     Glossary of Terms

List of Tables

Table 1.             North America In-Vitro Diagnostics Market Segmentation

Table 2.             US North America In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030  (US$ Million)

Table 3.             US North America In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 4.             US North America In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 5.             US North America In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 6.             Canada North America In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 7.             Canada North America In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 8.             Canada North America In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 9.             Canada North America In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 10.          Mexico North America In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 11.          Mexico North America In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 12.          Mexico North America In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 13.          Mexico North America In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms, North America In-Vitro Diagnostics Market

List of Figures

Figure 1.           North America In-Vitro Diagnostics Market Segmentation, By Country

Figure 2.           North America In-Vitro Diagnostics Market: Key Industry Dynamics

Figure 3.           North America In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 4.           North America In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 – 2030

Figure 5.           North America In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

Figure 6.           Reagents and Kits: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Software and Services: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Instruments: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           North America In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 10.        Immunoassay/ Immunochemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Clinical Chemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Molecular Diagnostics: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        Microbiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.        Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.        Coagulation and Hemostasis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

Figure 16.        Hematology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.        North America In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)

Figure 20.        Infectious Diseases: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Diabetes: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.        Oncology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Cardiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Autoimmune Diseases: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

Figure 25.        Nephrology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.        Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.        North America In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

Figure 28.        Hospitals: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        Laboratories: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Homecare: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.        North America: North America In-Vitro Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 33.        North America In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)

Figure 34.        US: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 35.        Canada: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 36.        Mexico: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)